Actively Recruiting
Resilience Through Interventions for Successful Early Outcomes
Led by University of North Carolina, Chapel Hill · Updated on 2026-02-02
150
Participants Needed
1
Research Sites
141 weeks
Total Duration
On this page
Sponsors
U
University of North Carolina, Chapel Hill
Lead Sponsor
U
University of California, San Francisco
Collaborating Sponsor
AI-Summary
What this Trial Is About
Purpose: The purpose of this research is to determine the effects of Attachment and Biobehavioral Catch-up (ABC), an evidence-based parenting program, on stress biomarkers in children. Participants: The study will involve approximately 150 caregiver-child dyads, with children aged between 24 and 42 months. Participants will include primary caregivers fluent in English or Spanish, along with their children who have experienced social risk factors for adversity. Procedures (Methods): Participants will be randomly assigned to either receive the ABC parenting program (10 sessions) immediately or be placed on a wait-list, receiving the program after about 4 months. The study procedures include caregivers completing online surveys, engaging in play-based observational tasks with their children, and collecting non-invasive biological samples (saliva, cheek swab, hair) from the children and saliva samples from the caregivers at 2-3 time-points.
CONDITIONS
Official Title
Resilience Through Interventions for Successful Early Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Caregiver aged 18 years or older
- Speaks English or Spanish
- Is the parent or legal guardian with custody of a child aged 24 to 42 months
- Is the primary caregiver or parent
- Has a home environment suitable for intervention participation
- Child aged between 24 and 42 months at enrollment
- Child lives with caregiver at least 50% of the time
- Child has experienced social risk factors like low income, community or family violence, trauma, separation from caregiver, or relationship difficulties
You will not qualify if you...
- Child has diagnosed genetic or congenital disorders such as Down syndrome, cerebral palsy, seizure disorders, endocrine disorders, or birth defects
- Child is using steroid medications including human growth hormone
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of North Carolina at Chapel Hill
Chapel Hill, South Carolina, United States, 27599
Actively Recruiting
Research Team
D
Danielle Rouvinov, PhD
CONTACT
N
Nicole Bush, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here